On November 4, 2024, Gilbert Fuller, Director at Usana Health Sciences Inc (USNA, Financial), executed a sale of 675 shares of the company. The transaction was filed on the same day with the SEC. Following this transaction, the insider now owns 0 shares of Usana Health Sciences Inc.
Usana Health Sciences Inc is a company that develops and manufactures nutritional supplements, healthy foods, and personal care products, which are marketed directly to consumers through a network of independent distributors.
Over the past year, Gilbert Fuller has sold a total of 2,330 shares of Usana Health Sciences Inc and has not made any purchases of the stock. The broader trend within the company shows a pattern of insider selling, with 22 insider sales and no insider buys over the past year.
On the date of the recent sale by the insider, shares of Usana Health Sciences Inc were priced at $37.71. This pricing gives the company a market cap of $738.564 million. The price-earnings ratio of the stock stands at 13.70, which is below both the industry median of 18.09 and the company's historical median.
According to the GF Value, which is an intrinsic value estimate used by GuruFocus, Usana Health Sciences Inc is considered Modestly Undervalued. The GF Value of $53.59 suggests a price-to-GF-Value ratio of 0.7.
The GF Value is calculated based on historical trading multiples such as the price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow, adjusted by a GuruFocus factor which considers past returns and growth, and future business performance estimates from analysts.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
